Two Common Compounds Show Effectiveness Against COVID-19 Virus in Early Testing
A pair of over-the-counter compounds has been found in preliminary tests to inhibit the virus that causes COVID-19, University of Florida Health researchers have found.
COVID-19 technology?
Our online portal is open and ready.
We have seen our inventors and entrepreneurs rise to the challenges brought by COVID-19 this past year, and we are thankful and proud of each one of you. We at UF Innovate are here to facilitate your efforts as you continue to invent, create entrepreneurial solutions, and do all you can to change the world for the better. We hope this page of resources and stories about how UF Innovate research and entrepreneurs are doing their part to help in this pandemic encourages and inspires you.
Apply Here
Small business owners can apply for a First Draw Loan from the Payroll Protection Program by the U.S. Small Business Administration. Applications still open.
Grants & Funding
Looking for program development and funding opportunities during COVID-19? Visit UF’s Emerging Pathogen’s Funding webpage to learn about available grants.
Latest UF Research
UF researchers continue to respond to the COVID-19 crisis by doing what they do best — finding answers and solutions. Read the latest research here.
Loan Guidelines
The U.S. Chamber of Commerce continues to help companies stay afloat and keep paychecks flowing and more. Details on relief package and vaccines here.
CORD-19 Dataset
Help generate new insights to fight COVID-19, collaborate with other researchers worldwide, participate in the CORD-19 Challenge. Learn more.
UF Health Facts
Get the fast facts about UF Health’s responses and learn about the work our researchers conduct to combat the global pandemic. The latest here.
Startup Advice
Do you have an idea for a startup? OUP’s tech and life sciences teams are offering free VC office hours to UF researchers. Sign up for a 30-minute complimentary session.
Funding Innovation
The Bill & Melinda Gates Foundation pledges millions to fund innovation that tackles COVID-19 challenges. Get the latest here.
Impact on Research
The coronavirus is a challenge impacting researchers at the university. UF Research is doing its best to keep researchers updated. More here.
UF Innovate Tech & Startups Aid the Fight
UF Health Scientists Develop Novel Method of Cryopreserving Lung Tissue for COVID-19 Research
A team of University of Florida Health researchers have developed a method to cryopreserve lung tissue at minus-184 degrees Fahrenheit that give scientists an important new tool to study how the coronavirus infects individuals.
UF Health Psychiatrist Talks About the Mental Health Challenges Posed by COVID-19
Jacqueline Hobbs, M.D., Ph.D., an associate professor in the University of Florida College of Medicine’s department of psychiatry, discusses the burden of coping with the stress caused by the upheaval of normal life and the need to pay closer attention to our mental well-being.
UF Health Expert Discusses COVID-19 Booster Shots
Michael Lauzardo, M.D., deputy director of UF’s Emerging Pathogens Institute and an associate professor in the UF College of Medicine’s department of medicine, talks about issues related to the third vaccine dose.
Oragenics Initiates COVID-19 Challenge Study Evaluating Multiple Formulations of Its SARS-CoV-2 Vaccine Candidate
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc. announced the initiation of a study to evaluate the immunogenicity and viral load reduction impact of its SARS-CoV-2 vaccine candidate in a hamster challenge study.
Oragenics’ SARS-CoV-2 Spike Protein Produces Neutralizing Antibodies in Mice With Intramuscular and Intranasal Adjuvants
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announces that the stabilized pre-fusion spike protein trimer produced by its Canadian collaborator and licensed by the company from the National Institutes of Health (NIH) generates neutralizing antibodies in mice after immunization against SARS-CoV-2, when administered with several novel intramuscular (IM) and intranasal (IN) adjuvants.
CFO of Life Science Startup Axogen Shares How Firm Navigated Pandemic’s Health Care Disruptions
UF startup and UF Innovate | Sid Martin Biotech graduate Axogen, a life science company that is developing products for nerve repair, is ramping up hiring for scientists and engineers after navigating through the negative disruptions from the Covid-19 pandemic.
Two-Year Backlog in Biologicals Manufacturing Hinders Medical R&D, Development of New Therapies for COVID-19
One area where COVID-19 has had a substantial impact is the development and manufacturing of medicines, medical devices, and pharmaceutical products. The CDMO industry is showing enormous growth and is projected to become a $315 billion industry by 2026. However, the demand for products skyrocketed so quickly that supply has not been able to keep pace. According to Dr. Ian White, president and CSO of Neobiosis, a UF Innovate | Sid Martin Biotech resident company that focuses on the science of regenerative medicine, demand has caused a two-year backlog of desperately needed cellular and acellular products for use in research and clinical trials directed at treating the COVID-19 virus and its complications (AKA Post-COVID Syndrome).
Breast Milk of Mothers Who Received COVID-19 Vaccine Contains Antibodies That Fight Illness
The breast milk of lactating mothers vaccinated against COVID-19 contains a significant supply of antibodies that may help protect nursing infants from the illness, according to new research from the University of Florida.
UF Health Team Develops Technique To Conserve Oxygen During Acute Shortages
With the oxygen shortage in mind, a team at the University of Florida Health’s Center for Safety, Simulation and Advanced Learning Technologies, or CSSALT, conceived a novel way to prolong the life of oxygen cylinders by reducing oxygen waste.